Cytoki Pharma Shows Promise for Lipidated IL-22 in IBD Management through Innovative Study Cytoki Pharma unveils significant findings on lipidated IL-22's effectiveness for IBD treatment, as published in Digestive Diseases and Sciences, presenting a potential breakthrough in managing this condition.

Cytoki Pharma Shows Promise for Lipidated IL-22 in IBD Management through Innovative Study #Denmark #Søborg #IBD #Cytoki_Pharma #IL-22